Stock Events

Stock Events

Spero Therapeutics (SPRO) Q2 2026 Earnings

13MayConfirmed

Q2 2025

Q3 2025

Q4 2025

Q2 2026

-0.55

-0.38

-0.2

-0.03

Details

Expected EPS

-0.18

Actual EPS

-0.13

Surprise EPS

0.05

Surprise Percent

+27.78%

Description

Spero Therapeutics (SPRO) has reported earnings of -0.13 per share for Q2 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.